Table 3 Effect of inactivation protocols in salivary biomarkers of metabolic status, kidney function and tissue damage [median (25–75 percentile)].

From: Effect of thermal and chemical treatments used for SARS-COV-2 inactivation in the measurement of saliva analytes

Analyte

TT1

TT2

TT3

TT4

TT5

TT6

P

AST, IU/L

19.00 (16.5–20.95)

7.9* (4.65–10.08)

0.35* (0.15–0.85)

0.75* (0.15–1.7)

18.65 (13.3–20.95)

19.45 (14.1–20.625)

 < 0.001

ALT, IU/L

5.3 (3.825–7)

1.65* (1.075–2.25)

1.6* (1.375–2.075)

1.55* (1.2–2.2)

4.45 (2.925–6.1)

4.05 (2.95–6.2)

 < 0.001

CK, IU/L

19.75 (12.375–29.5)

0.25* (0–2.075)

0.3* (0–1.05)

0.7* (0–3)

15.95 (12.325–20.675)

17.6 (12.175–21.5)

 < 0.001

LDH, IU/L

293.3 (220.625–420.175)

4.45* (2.75–5.8)

1.8* (0.525–3.375)

1.5* (0.45–4.05)

283.6 (214.2–406.325)

282.95 (216.375–417.8)

 < 0.001

Urea, mmol/L

9.98 (8.60–10.75)

10.0 (8.59–11.02)

10.3 (8.76–11.21)

9.10* (7.80–9.85)

9.69 (8.31–10.77)

9.73 (8.59–11.08)

 < 0.001

Creatinine, µmol/L

7.96 (5.08–11.05)

7.96 (5.08–11.27)

6.19 (1.77–11.71)

7.51 (5.75–10.17)

7.51 (5.30–11.27)

7.51 (6.19–9.50)

0.382

Total cholesterol, mmol/L

6.1 × 10–3 (9.8 × 10–4–8.5 × 10–3)

1.19 × 10–2 (5.18 × 10–3–1.67 × 10–2)

1.26 × 10–2 (1.09 × 10–2–1.42 × 10–2)

8.29 × 10–3 (1.17 × 10-3–1.84 × 10–2)

8.03 × 10–3 (0–1.02 × 10–2)

1.18 × 10–2 (2.85 × 10–3–1.37 × 10–2)

0.0417

Triglycerides, mmol/L

0.031 (0.027–0.055)

0.036 (0.025–0.057)

0.034 (0.017–0.062)

0.154* (0.120–0.188)

0.105* (0.091–0.126)

0.104* (0.093–0.117)

 < 0.001

Glucose, mmol/L

0.014 (4.44 × 10–3–5,6 × 10–2)

8.32 × 10–3 (3.89 × 10–3–6.32 × 10–2)

3.33 × 10–3 (5,56 × 10–4–5,49 × 10–2)

2.00 × 10-2* (5.56 × 10–4–9.88 × 10–2)

2.83 × 10–2* (7.22 × 10–3–0.110)

2.44 × 10–2* (7.22 × 10–3–0.109)

 < 0.001

CA, mmol/L

1.28 (1.05–1.39)

1.05 (0.85–1.29)

1.04 (0.90–1.29)

1.21 (1.03–1.44)

1.24 (1.03–1.38)

1.24 (1.03–1.42)

0.114

P, mmol/L

4.70 (4.08–5.49)

4.72 (4.27–5.42)

4.74 (4.23–5.56)

4.51* (3.79–5.25)

4.49 (4.17–5.37)

4.59 (4.17–5.49)

0.001

Lactate, µmol/L

1.755 (0.905–2.33)

1.805 (0.985–2.3275)

1.8 (0.94–2.295)

1.765 (0.3425–2.3125)

1.705* (0.8175–2.113)

1.745* (0.855–2.178)

 < 0.001

ChE, IU/L

4.1 (2.3–8.45)

3.1 (1.3–5.4)

2.3* (0.8–3.6)

2.8* (1.6–5.2)

3.9 (1.3–6.0)

4.2 (1.4–5.8)

 < 0.001

  1. Significant values are in bold.
  2. *P < 0.05. Control (TT1); 65 °C 30 min (TT2); 92 °C 15 min (TT3); SDS (TT4); NP40 (TT5) and triton (TT6).